Ab&B fortifies for battle over China’s vaccine market
With proceeds from a Hong Kong IPO, the loss-making biotech is bidding for a piece of China’s fiercely competitive market for flu and human rabies vaccines Key Takeaways: The company’s…
Apple’s China puzzle and an African phone pioneer’s peril
Apple returns to revenue growth in China, as it also closes its first store in the city of Dalian. What's next for the company in the world's largest smartphone market? And Transsion considers a Hong Kong IPO. Should investors buy into this biggest smartphone maker you've never heard of, banking on its status as Africa's top cellphone brand?
IPO applicant Lemo faces cash squeeze and credibility questions
The operator of massage chairs in public spaces is making a renewed pitch to investors amid a lingering controversy about its business data Key Takeaways: The firm deploys massage chairs…
Zhida seeks to recharge its finances with another IPO bid
The maker of charging techology for electric vehicles risks running out of juice to manage its cash flow and fund its international expansion plans Key Takeaways: The company managed to…
China’s new investment playbook: VCs chase crypto as a travel upstart eyes New York
Chinese venture capital firms are embracing cryptocurrencies. And up-and-coming online travel agent Klook is eying a major New York IPO.
Aux Electric blows into Hong Kong with IPO application
The air conditioner maker’s low-price strategy has helped it win customers in China, while its OEM model has won over customers abroad Key Takeaways: Aux Electric achieved 20% revenue growth…
Hong Kong: China’s IPO pipeline and crypto lab
Companies raised $13.6 billion through Hong Kong IPOs in the first half of the year, giving the city the global fundraising title for that period. What's behind the sudden boom? And a growing number of Chinese companies are experimenting with cryptocurrencies in Hong Kong, even as such currencies are banned on the Mainland. What's driving such different approaches on the Mainland and in Hong Kong?
Recent Articles
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
- Anti-toxin provider Jiangxi Institute joins biopharma IPO rush
-
Biogene gets bruised in ‘Battle of the skincare belles’
2367.HK 688363.SHG
-
JD.com sets up Hong Kong bridgehead as real-time retail battle moves overseas
9618.HK JD.US
- Switchbot taps market frenzy for robotic stocks
-
Unisound launches modest IPO into crowded Hong Kong market
9678.HK
